Dr. Abeer Alharbi holds a Bachelor of Science in Pharmaceutical Sciences with first-class honors from the College of Pharmacy at King Saud University, a Master of Science in Experimental and Clinical Pharmacology from the University of Minnesota, and a Doctor of Philosophy in Pharmacology from the University of Oxford.

Dr. Alharbi is passionate about the fields of pharmacogenomics, cancer genomics, and oncoimmunology. She was awarded a short-term fellowship from the European Society of Medical Oncology and has published several scientific articles in reputable journals.

Her scientific and leadership contributions during her DPhil studies have been recognized with several prestigious awards, including the 2022 Simon, Arpi, Marie, and John Simonian Prize for Excellence in Leadership from St Edmund Hall, University of Oxford, the 2021 Woman in Cancer Research Scholar Award from the American Association for Cancer Research, and the 2021 Tony Doyle Graduate Science Prize from St Edmund Hall, University of Oxford.